What's New

Last Posted: Dec 17, 2020

• Genetic testing is essential for initiating statin therapy in children with familial hypercholesterolemia: Examples from Scandinavia.
  Svendsen Karianne et al. Atherosclerosis 2020 Dec 31648-52
• Life by the Numbers: Living with Familial Hypercholesterolemia.
  Walsh Casey Mulligan et al. Circulation. Genomic and precision medicine 2020 Dec
• Clinical Diagnostic Criteria of Familial Hypercholesterolemia　- A Comparison of the Japan Atherosclerosis Society and Dutch Lipid Clinic Network Criteria.
  Tada Hayato et al. Circulation journal : official journal of the Japanese Circulation Society 2020 Dec
• Evinacumab in Patients with Refractory Hypercholesterolemia.
  Rosenson Robert S et al. The New England journal of medicine 2020 Dec 383(24) 2307-2319
• Novel therapies for familial hypercholesterolemia.
  Mohamed Farzahna et al. Current opinion in endocrinology, diabetes, and obesity 2020 Dec
• Familial Hypercholesterolemia: A Reportable Disorder.
  Kullo Iftikhar J et al. Circulation 2020 Nov 142(21) 1999-2001
• Cascade screening and genetic diagnosis of familial hypercholesterolemia in clusters of the Southeastern region from Brazil.
  de Paiva Silvino Júnea Paolucci et al. Molecular biology reports 2020 Nov
• Analysis of Arterial Stiffness and Sexual Function after Adding on PCSK9 Inhibitor Treatment in Male Patients with Familial Hypercholesterolemia: A Single Lipid Center Real-World Experience.
  Scicali Roberto et al. Journal of clinical medicine 2020 Nov 9(11)
• Familial Hypercholesterolemia in Premature Acute Coronary Syndrome. Insights from CholeSTEMI Registry.
  Lorca Rebeca et al. Journal of clinical medicine 2020 Oct 9(11)
• Genetics of Familial Hypercholesterolemia: New Insights.
  Vrablik Michal et al. Frontiers in genetics 2020 11574474
• Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.
  Huijgen Roeland et al. Arteriosclerosis, thrombosis, and vascular biology 2020 Nov ATVBAHA120314482
• A reassessment of the Japanese clinical diagnostic criteria of familial hypercholesterolemia in a hospital-based cohort using comprehensive genetic analysis.
  Tada Hayato et al. Practical laboratory medicine 2020 Nov 22e00180
• Prevalence, self-awareness, and LDL cholesterol levels among patients highly suspected as familial hypercholesterolemia in a Japanese community.
  Tada Hayato et al. Practical laboratory medicine 2020 Nov 22e00181
• Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects.
  Duprez Daniel A et al. Vascular health and risk management 2020 16403-418
• Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care
  RK Akyea et al, NPJ Digital Medicine, October 30, 2020